Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
1.210
-0.030 (-2.42%)
At close: Jun 13, 2025, 4:00 PM
1.250
+0.040 (3.31%)
After-hours: Jun 13, 2025, 5:38 PM EDT
Enveric Biosciences Market Cap
Enveric Biosciences has a market cap or net worth of $2.99 million as of June 13, 2025. Its market cap has decreased by -49.24% in one year.
Market Cap
2.99M
Enterprise Value
-1.30M
1-Year Change
-49.24%
Ranking
Category
Stock Price
$1.21
Market Cap Chart
Since December 31, 2020, Enveric Biosciences's market cap has decreased from $11.31B to $2.99M, a decrease of -99.97%. That is a compound annual growth rate of -84.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 13, 2025 | 2.99M | -17.95% |
| Dec 31, 2024 | 3.64M | 20.78% |
| Dec 29, 2023 | 3.02M | -30.19% |
| Dec 30, 2022 | 4.32M | -85.19% |
| Dec 31, 2021 | 29.19M | -99.74% |
| Dec 31, 2020 | 11.31B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 728.15B |
| Johnson & Johnson | 375.41B |
| Novo Nordisk | 353.21B |
| AbbVie | 339.75B |
| UnitedHealth Group | 281.21B |
| Abbott Laboratories | 237.59B |
| Novartis AG | 231.84B |
| AstraZeneca | 229.07B |